» Articles » PMID: 33129243

The Involvement of Protein Kinases in the Cardioprotective Effect of Chronic Hypoxia

Overview
Journal Physiol Res
Specialty Physiology
Date 2020 Nov 1
PMID 33129243
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this review is to analyze the involvement of protein kinases in the cardioprotective mechanism induced by chronic hypoxia. It has been reported that chronic intermittent hypoxia contributes to increased expression of the following kinases in the myocardium: PKCdelta, PKCalpha, p-PKCepsilon, p-PKCalpha, AMPK, p-AMPK, CaMKII, p-ERK1/2, p-Akt, PI3-kinase, p-p38, HK-1, and HK-2; whereas, chronic normobaric hypoxia promotes increased expression of the following kinases in the myocardium: PKCepsilon, PKCbetaII, PKCeta, CaMKII, p-ERK1/2, p-Akt, p-p38, HK-1, and HK-2. However, CNH does not promote enhanced expression of the AMPK and JNK kinases. Adaptation to hypoxia enhances HK-2 association with mitochondria and causes translocation of PKCdelta, PKCbetaII, and PKCeta to the mitochondria. It has been shown that PKCdelta, PKCepsilon, ERK1/2, and MEK1/2 are involved in the cardioprotective effect of chronic hypoxia. The role of other kinases in the cardioprotective effect of adaptation to hypoxia requires further research.

References
1.
Gu S, Hua H, Guo X, Jia Z, Zhang Y, Maslov L . PGC-1α Participates in the Protective Effect of Chronic Intermittent Hypobaric Hypoxia on Cardiomyocytes. Cell Physiol Biochem. 2018; 50(5):1891-1902. DOI: 10.1159/000494869. View

2.
Zhang H, Liu B, Li T, Zhu Y, Luo G, Jiang Y . AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia. Int J Mol Med. 2017; 41(1):69-76. PMC: 5746297. DOI: 10.3892/ijmm.2017.3213. View

3.
Vigano A, Vasso M, Caretti A, Bravata V, Terraneo L, Fania C . Protein modulation in mouse heart under acute and chronic hypoxia. Proteomics. 2011; 11(21):4202-17. DOI: 10.1002/pmic.201000804. View

4.
Okubo S, Tanabe Y, Fujioka N, Takeda K, Takekoshi N . Differential activation of protein kinase C between ischemic and pharmacological preconditioning in the rabbit heart. Jpn J Physiol. 2003; 53(3):173-80. DOI: 10.2170/jjphysiol.53.173. View

5.
Milano G, Morel S, Bonny C, Samaja M, von Segesser L, Nicod P . A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo. Am J Physiol Heart Circ Physiol. 2006; 292(4):H1828-35. DOI: 10.1152/ajpheart.01117.2006. View